5 Recruiting Chronic Inflammatory Demyelinating Polyneuropathy Phase 3 Clinical Trials
Active phase 3 studies for chronic inflammatory demyelinating polyneuropathy enrolling across the USA. Verify eligibility and contact site coordinators.
All Chronic Inflammatory Demyelinating Polyneuropathy studiesPhase 3 Studies for Chronic Inflammatory Demyelinating Polyneuropathy
🟢 Recruiting Phase3
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
📍 Alabama Neurology Associates- Site Number : 8400019 — Homewood, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
📍 USF Health - Morsani Center for Advanced Healthcare — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
📍 University of Alabama at Birmingham - 1720 University Blvd — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
📍 Clinical Study Site — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
📍 University of Alabama — Birmingham, Alabama
View Study & Checklist ➔